- Home
- BEAT vs TACT Comparison
BEAT vs TACT Comparison
Compare BEAT & TACT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BEAT
- TACT
- Stock Information
- Founded
- BEAT 2015
- TACT 1996
- Country
- BEAT United States
- TACT United States
- Employees
- BEAT N/A
- TACT N/A
- Industry
- BEAT Retail: Computer Software & Peripheral Equipment
- TACT Computer peripheral equipment
- Sector
- BEAT Technology
- TACT Technology
- Exchange
- BEAT Nasdaq
- TACT Nasdaq
- Market Cap
- BEAT 37.7M
- TACT 42.2M
- IPO Year
- BEAT 2021
- TACT 1996
- Fundamental
- Price
- BEAT $1.33
- TACT $4.70
- Analyst Decision
- BEAT Buy
- TACT Strong Buy
- Analyst Count
- BEAT 1
- TACT 1
- Target Price
- BEAT $8.00
- TACT $5.00
- AVG Volume (30 Days)
- BEAT 119.2K
- TACT 71.0K
- Earning Date
- BEAT 11-06-2025
- TACT 11-06-2025
- Dividend Yield
- BEAT N/A
- TACT N/A
- EPS Growth
- BEAT N/A
- TACT N/A
- EPS
- BEAT N/A
- TACT N/A
- Revenue
- BEAT N/A
- TACT $47,949,000.00
- Revenue This Year
- BEAT N/A
- TACT $21.67
- Revenue Next Year
- BEAT N/A
- TACT $7.63
- P/E Ratio
- BEAT N/A
- TACT N/A
- Revenue Growth
- BEAT N/A
- TACT N/A
- 52 Week Low
- BEAT $0.91
- TACT $3.12
- 52 Week High
- BEAT $3.48
- TACT $4.89
- Technical
- Relative Strength Index (RSI)
- BEAT 56.41
- TACT 71.45
- Support Level
- BEAT $1.27
- TACT $4.09
- Resistance Level
- BEAT $1.54
- TACT $4.74
- Average True Range (ATR)
- BEAT 0.10
- TACT 0.20
- MACD
- BEAT 0.02
- TACT 0.02
- Stochastic Oscillator
- BEAT 53.88
- TACT 93.85
About BEAT Heartbeam Inc.
HeartBeam Inc is a medical technology company is focusing on developing and commercializing higher resolution ambulatory Electrocardiogram ("ECG") solutions that enable the detection and monitoring of cardiac disease outside a healthcare facility setting. The Company's ability to develop higher-resolution ECG solutions is achieved through the development of the Company's proprietary and patented Vector Electrocardiography ("VECG") technology platform. The Company has validated this technology and is seeking U.S. Food and Drug Administration ("FDA") clearance for its initial telehealth products.
About TACT TransAct Technologies Incorporated
Transact Technologies Inc develops and sells software-driven technology and printing solutions. The company's software is sold under BOHA, AccuDate, Epic, EPICENTRAL, Ithaca, and Printrex brand names. It also provides supplies and consumables used in the printing and scanning activities to restaurant and hospitality, banking, retail, casino and gaming, point of sale automation, lottery, medical, mobile, oil, and gas markets. Majority of the revenue is derived from the casinos and gaming industry followed by the Foodservice technology market. Its geographical segments are the United States and International, of which the majority of its revenue comes from the United States.